Zucara Therapeutics Inc.
Clinical trials sponsored by Zucara Therapeutics Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to stop dangerous nighttime hypos in type 1 diabetes Results expected Dec 2026 (estimated)